Vuja De Sciences
Hoboken, NJ
Vuja De Sciences develops cancer metastasis treatments that prevent cancer progression and recurrence. They utilize leading laboratory technologies for metastatic preclinical endpoints in combination with Comparative Oncology to de-risk and inform product development and maximize the likelihood of successful human oncology clinical trials. It approaches used for cancer maintenance therapy and adjuvant therapy target the same mechanisms applied to either primary tumors or macro-metastatic tumors.
vujade-life.comCompany Details
Founded
- 2017
Employees
- Between 5 - 20 employees
Raised
- $2,467,400
Headquarters Location
- Hoboken, NJ
Public
- No
Acquired
- No
CEO
- David Warshawsky
Founders
- Raphael NirDavid WarshawskyRick LampeRobert E. Hurst
Company Collections
These are collections Vuja De Sciences is a part of. Click on the collection name to view similar companies.